CGI leverages expertise in healthcare regulatory
issues
"HIPAA will have a profound impact on our
business, both from a technology and operational standpoint. We chose
CGI because of its national reputation on healthcare regulatory issues
and its high-end technology capabilities."
John Proctor, Vice-President Corporate Affairs,
BlueCross BlueShield Mississippi
For more than a decade, CGI has provided a broad spectrum of healthcare
consulting services focusing on regulatory compliance in the payer and
provider markets. BlueCross BlueShield engaged CGI's expertise in its
efforts to comply with the U.S. Health Insurance Portability and Accountability
Act (HIPAA).
The Challenge
BlueCross BlueShield of Mississippi, a for-profit mutual insurance company,
offers its clients the largest network of doctors, hospitals, and other
healthcare providers available in the state. With more than 1,000 employees,
advanced technology, and a strong commitment to excellent service, the
company processes approximately 10 million healthcare claims and pays
out more than $1 billion in medical expenses each year.
Under the HIPAA, the U.S. Secretary of Health and Human Services is authorized
to promulgate regulations necessary to achieve several goals of administrative
simplification within the healthcare industry. The goals include developing
electronic standards for healthcare transactions, ensuring the security
of healthcare data and systems, and protecting the privacy of personal
health information. In light of these developments, BlueCross BlueShield
recognized the need for assistance to achieve its goals of regulatory
compliance, understanding and interpreting HIPAA regulations, and educating
the entire organization on HIPAA and its impact. CGI's noted expertise
in healthcare consulting coupled with its understanding of the new HIPAA
regulation and its effect on healthcare organizations, was precisely the
medicine the insurer was looking for.
The Strategy
CGI's mandate was to conduct a HIPAA impact assessment and gap analysis
that would take into account the insurer's applications, systems, vendors,
and partners. Prior to the assessment, CGI developed and conducted multiple
educational programs for company executives and senior management. CGI
put together an impressive consulting team that included experts in claims
processing, transaction and codes sets, national identifiers, security,
privacy, and technical training. In their analysis, the team would examine
the cost of resources, opportunities, risks, and other significant budgetary
impacts.
The Technology
The Results
CGI conducted a gap analysis and developed an impact report for the business
areas of the company. Business areas examined included claims (medical,
pharmacy); corporate accounts administration, including re-insurance,
membership, and billing; customer service; marketing, underwriting; utilization
management (case management), provider contracting; provider credentialing;
security administration policies and procedures and infrastructure components
and compliance. A similar gap analysis was provided for the company's
hardware and software components and for third-party interfaces.
With CGI's HIPAA knowledge and its compliance experience, BlueCross BlueShield
now has a complete and detailed assessment of the risk areas and impact
that the HIPAA transaction and code set regulations will have on its business.
The assessment took into account the company's corporate strategy and
e-business plans. Moreover, CGI's organization-specific training provided
the information necessary to use the detailed analysis and recommendations
to develop a strategic remediation plan to gain HIPAA compliance. And
in the process, BlueCross BlueShield was able to benefit from the required
knowledge and expertise without adding staff or removing staff away from
mission-critical work. Said John Proctor, Vice-President of Corporate
Affairs at BlueCross BlueShield, "HIPAA will have a profound impact
on our business, both from a technology and operational standpoint. We
chose CGI because of its national reputation on healthcare regulatory
issues and its high-end technology capabilities."
|